J&J Co-Authored Today's Landmark Report About AIDX's Pentavere AI Breakthrough

Johnson & Johnson Innovative Medicine aka Janssen co-authored today's landmark publication about Healwell AI (TSX: AIDX)'s breakthrough Pentavere AI technology entitled:

'Real-World Outcomes of Patients with Advanced Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer in Canada Using Data Extracted by Large Language Model-Based Artificial Intelligence.'

Click here to read today's newly published landmark report about AIDX's Pentavere AI breakthrough for cancer detection using Large Language Models!

Now do you understand why we said AIDX is executing better than any other AI company in the world!?

Remember, the largest AIDX shareholder is Well Health (TSX: WELL) and one of WELL's largest shareholders is Li Ka-shing the wealthiest man in Hong Kong!

Stop doubting us about AIDX and Augusta Gold (TSX: G)! We will be proven right about both companies!

Watch where AIDX and G are trading at the end of this month!

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA's President has purchased 224,200 shares of G in the open market and intends to buy more shares. NIA has received compensation from AIDX of US$50,000 cash for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.